• FH1 Small Molecule (B3700): Next-Gen Hepatocyte Engineering

  2026-08-04

  Explore how the FH1 small molecule drives advanced cultured hepatocyte function enhancement and iPS cell differentiation to hepatocytes. This article uncovers mechanistic depth, protocol precision, and translational opportunities distinct from existing content.

• Intravesical p21 mRNA-LNP: A New Tumor Suppressor Therapy in

  2026-08-04

  This study introduces a localized mRNA-based tumor suppressor replacement therapy for bladder cancer using p21 mRNA-loaded lipid nanoparticles (LNPs). The innovative approach demonstrates effective restoration of p21 function, tumor growth suppression, and preserved bladder tissue architecture, highlighting the translational promise of mRNA-LNP therapeutics for non-muscle-invasive bladder cancer.

• EV-Transferred ACLY Drives TAM Differentiation in HCC

  2026-08-03

  This study uncovers how hepatocellular carcinoma (HCC) cells transfer ATP-citrate lyase (ACLY) via extracellular vesicles to monocytes, reprogramming them into immunosuppressive tumor-associated macrophages (TAMs). The findings reveal a metabolic mechanism underlying immune evasion in HCC and suggest that targeted inhibition of EV-mediated ACLY can help improve immunotherapy outcomes.

• Octenidine Dihydrochloride: Biophysical Mechanisms and Assay

  2026-08-03

  Discover the scientific foundation of Octenidine dihydrochloride as a research-grade antiseptic. This in-depth article explores membrane-disruptive mechanisms, biophysical assay considerations, and how to leverage Octenidine for advanced antimicrobial research.

• Tobramycin in Microbiology: Protocols, Pitfalls, and Researc

  2026-08-02

  Harness Tobramycin’s high water solubility and robust antibacterial spectrum for reproducible Gram-negative infection models and antibiotic resistance research. This article details practical workflows, comparative insights, and troubleshooting strategies, empowering scientists to optimize experimental outcomes in microbiology and molecular biology.

• Baicalin Methyl Ester: Applied Workflows for Intestinal Barr

  2026-08-01

  Baicalin methyl ester, an esterified derivative of baicalin, offers robust protection against LPS-induced intestinal barrier damage by modulating the P65/TNF-α/MLCK/ZO-1 pathway. This article distills the latest research into actionable protocols, troubleshooting strategies, and advanced applications for intestinal inflammation models.

• PNU 74654: Reliable Wnt Signaling Pathway Inhibitor Workflow

  2026-07-31

  PNU 74654, a potent Wnt signaling pathway inhibitor from APExBIO, empowers researchers to modulate cell proliferation and differentiation with high precision in cancer and stem cell assays. This guide delivers actionable experimental workflows, troubleshooting strategies, and protocol optimizations anchored in cutting-edge peer-reviewed findings.

• ZPR1 Phase Separation Regulates UPRER: Insights from EPEC Ef

  2026-07-31

  Ouyang et al. uncover how the enteropathogenic E. coli effector NleE disrupts the liquid-liquid phase separation (LLPS) of the host zinc finger protein ZPR1, thereby antagonizing the unfolded protein response of the endoplasmic reticulum (UPRER). Their work reveals a novel bacterial immune evasion mechanism with significant implications for studying transcriptional regulation and stress responses.

• ZK53 and the Future of Mitochondrial ClpP Activation in Canc

  2026-07-30

  This thought-leadership article explores the strategic deployment of ZK53, a selective human mitochondrial serine protease ClpP activator, in translational cancer research. It integrates mechanistic insight, experimental validation, and emerging opportunities, while situating ZK53 within a landscape shaped by recent advances in metabolic and translational control.

• Chlorin e6 in Photodynamic Therapy: Mechanisms and Translati

  2026-07-30

  This thought-leadership article explores the advanced mechanistic basis, experimental breakthroughs, and translational strategies surrounding Chlorin e6 (Ce6) as a second-generation photosensitizer in photodynamic therapy (PDT). Building on recent evidence that Ce6-mediated PDT induces both apoptosis and pyroptosis—thereby amplifying anti-tumor immunity—the article provides actionable guidance for translational researchers. It uniquely bridges mechanistic insight with protocol optimization, clinical relevance, and future outlook, while referencing the latest breakthroughs and APExBIO’s rigorously validated Ce6 product.

• Conserved Gene Expression Patterns in Mammalian Claustrum Su

  2026-07-29

  The reference study delivers a rigorous cross-species analysis of gene expression in the mammalian claustrum, revealing conserved molecular and spatial organization despite substantial brain size differences. These findings advance the understanding of claustrum architecture, offering a molecular framework for comparative neurobiology and translational research.

• Honokiol in Translational Immunometabolism: Strategic Insigh

  2026-07-29

  This article examines Honokiol as a mechanistically distinct tool for translational researchers investigating immune metabolism, tumor microenvironment modulation, and the NF-κB pathway. Drawing on the latest findings in T-cell metabolic flexibility and integrating lessons from in vitro assay optimization, it provides actionable recommendations for leveraging Honokiol to drive innovation in cancer and inflammation research.

• Merbromin: Bridging Protein Analysis and Antiviral Discovery

  2026-07-28

  Explore how Merbromin (Mercury dibromofluorescein disodium salt) is transforming translational research through its dual roles as a sensitive protein–ligand interaction probe and a potent, selective mixed-type inhibitor of viral proteases such as SARS-CoV-2 3CLpro. This article delivers mechanistic insights, actionable experimental guidance, and strategic perspective for translational teams, referencing key studies while differentiating the APExBIO offering for advanced biochemical and antiviral workflows.

• Intracellular Actions of Aminopeptidase Inhibitors in Myelom

  2026-07-28

  This article examines how bestatin and actinonin suppress myeloma cell proliferation primarily through intracellular mechanisms, rather than by inhibiting cell surface aminopeptidases. The study highlights the role of drug efflux systems and provides mechanistic insight for researchers exploring calcium channel blockers like Verapamil HCl in modulating intracellular drug accumulation and apoptosis.

• AP1903: FKBP-Binding Ligand for Controlled Cell Ablation Wor

  2026-07-27

  AP1903 unlocks nanomolar precision for conditional cell ablation and signal pathway research, outperforming traditional dimerizers in both potency and workflow scalability. Discover how this FKBP-binding ligand streamlines advanced multiplexed assays for functional genomics and viral receptor compatibility studies.

16398 records 1/1094 page Next 12345 下5页 Last page